U.S. federal trademark · Serial No. 88813905
Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.